PALO ALTO, Calif., April 10, 2024 -- BridgeBio Pharma, Inc. , a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that on April 5, 2024, the...

Related Keywords

Vikram Bali , Linkedin , Bio Pharma Inc , Twitter , Nasdaq , Bridgebio Pharma Inc , Bio Pharma , Equity Plan , Nasdaq Listing Rule , Bridgebio Pharma , Bio Contact , Markets ,